FCM
APGE icon

Frontier Capital Management’s Apogee Therapeutics APGE Stock Holding History

Frontier Capital Management’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.6M Buy
1,064,483
+584,030
+122% +$42.4M 0.92% 19
2025
Q4 		$36.3M Buy
480,453
+106,046
+28% +$6.68M 0.38% 86
2025
Q3 		$14.9M Buy
374,407
+65,341
+21% +$2.49M 0.13% 214
2025
Q2 		$13.4M Buy
309,066
+200,249
+184% +$7.62M 0.12% 217
2025
Q1 		$4.07M Sell
108,817
-63,894
-37% -$2.47M 0.04% 260
2024
Q4 		$7.82M Sell
172,711
-138,605
-45% -$7.07M 0.07% 235
2024
Q3 		$18.3M Buy
+311,316
New +$14.9M 0.17% 177
2024
Q2 		– Sell
-76,481
Closed -$5.08M – 281
2024
Q1 		$5.08M Buy
+76,481
New +$3.34M 0.05% 246

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Frontier Capital Management's APGE Position: Q1 2026 in Review

Frontier Capital Management increased its Apogee Therapeutics (APGE) stake by 122% in Q1 2026, buying an estimated $42.4M and bringing the position to 1,064,483 shares worth $89.6M. The position accounts for 0.92% of the portfolio, ranked #19.

Frontier Capital Management first reported a position in APGE in Q1 2024 and has held it in 8 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Frontier Capital Management held 1,064,483 shares of Apogee Therapeutics worth $89.6M as of Q1 2026.
  • Frontier Capital Management bought 584,030 Apogee Therapeutics shares in Q1 2026, an estimated $42.4M.
  • Apogee Therapeutics made up 0.92% of Frontier Capital Management's portfolio in Q1 2026, its #19 holding.
  • Frontier Capital Management first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.